Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 30% or More Changes in Sales or Profits/Losses (15% or More in the case of Large-scale Corporations) 2021/01/19 HANALL BIOPHARMA CO.,LTD
9 Interim Report on Business Performance(Fair Disclosure) 2021/01/19 HANALL BIOPHARMA CO.,LTD
8 [Revised]Organization of Investor Relations Event 2020/12/21 HANALL BIOPHARMA CO.,LTD
7 Closure of Stock Transfer (Shareholder's Registry) 2020/12/16 HANALL BIOPHARMA CO.,LTD
6 [Revised]Organization of Investor Relations Event 2020/11/03 HANALL BIOPHARMA CO.,LTD
5 Interim Report on Business Performance(Fair Disclosure) 2020/10/29 HANALL BIOPHARMA CO.,LTD
4 [Revised]Organization of Investor Relations Event 2020/10/23 HANALL BIOPHARMA CO.,LTD
3 Organization of Investor Relations Event 2020/10/19 HANALL BIOPHARMA CO.,LTD
2 [Revised]Organization of Investor Relations Event 2020/08/18 HANALL BIOPHARMA CO.,LTD
1 Organization of Investor Relations Event 2020/08/14 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
3 2019 Statement of financial position 2020-03-20
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31